Literature DB >> 22252480

Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample: the Brisighella Heart Study.

Arrigo F G Cicero1, Sergio D'Addato, Maddalena Veronesi, Martina Rosticci, Francesca Santi, Ada Dormi, Claudio Borghi.   

Abstract

OBJECTIVE: The objective is to evaluate the relationship between cholesterolemia, serum apolipoprotein B (apoB) level and blood pressure in a large sample of general population.
METHODS: The Brisighella Heart Study (BHS) is a prospective, population-based longitudinal epidemiological investigation. For this study, we analysed the data sampled in the 2008 BHS population survey, excluding those participants treated with antihypertensive and/or lipid lowering drugs (N: 2473).
RESULTS: In a sex, BMI, smoking habit, physical activity level and serum creatinine adjusted model, low-density lipoprotein-cholesterol (LDL-C) appears to be significantly related to SBP (P < 0.001), DBP (P = 0.026), and pulse pressure (PP) (P < 0.001). In individuals aged less than 52 years, LDL-C was significantly associated to SBP and DBP (P < 0.001), but not PP. In the same model, apoB appears to be mildly but significantly related to SBP (P < 0.001), DBP (P < 0.001), and PP (P < 0.001). In individuals aged less than 52 years, apoB was significantly associated to SBP (P < 0.001), DBP (P < 0.001), and PP (P < 0.001). In individuals aged 52 or more, nor LDL-C neither apoB were significantly associated to blood pressure. Including in the same model LDL-C and apoB, apoB excluded the predicting role of LDL-C as it regards the blood pressure either in the whole population sample and in the younger individuals.
CONCLUSION: On the basis of our observation, either serum LDL-C and apoB are significantly related to the blood pressure level in a large sample of individuals untreated with antihypertensive and lipid-lowering drugs. This association is stronger in younger individuals than in elderly. ApoB seems to be a stronger predictor of either SBP, DBP and PP than LDL-C.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252480     DOI: 10.1097/HJH.0b013e32834f6b11

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella Study.

Authors:  Arrigo Francesco Giuseppe Cicero; Giovambattista Desideri; Giulia Grossi; Riccardo Urso; Martina Rosticci; Sergio D'Addato; Claudio Borghi
Journal:  Intern Emerg Med       Date:  2014-07-02       Impact factor: 3.397

2.  Relationship between serum uric acid and electrocardiographic alterations in a large sample of general population: data from the Brisighella Heart Study.

Authors:  Arrigo F G Cicero; Martina Rosticci; Alessandra Reggi; Giuseppe Derosa; Angelo Parini; Elisa Grandi; Sergio D'Addato; Claudio Borghi
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-12-16

3.  Integrating Health Data-Driven Machine Learning Algorithms to Evaluate Risk Factors of Early Stage Hypertension at Different Levels of HDL and LDL Cholesterol.

Authors:  Pen-Chih Liao; Ming-Shu Chen; Mao-Jhen Jhou; Tsan-Chi Chen; Chih-Te Yang; Chi-Jie Lu
Journal:  Diagnostics (Basel)       Date:  2022-08-14

4.  Apolipoprotein B Levels Predict Future Development of Hypertension Independent of Visceral Adiposity and Insulin Sensitivity.

Authors:  Seung Jin Han; Wilfred Y Fujimoto; Steven E Kahn; Donna L Leonetti; Edward J Boyko
Journal:  Endocrinol Metab (Seoul)       Date:  2020-06-24

5.  The relationship between lipid risk score and new-onset hypertension in a prospective cohort study.

Authors:  Hankun Xie; Qian Zhuang; Jialing Mu; Junxiang Sun; Pengfei Wei; Xianghai Zhao; Yanchun Chen; Jiayi Dong; Changying Chen; Lai Wei; Yunjie Yin; Song Yang; Chong Shen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-28       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.